GSK, Pfizer head into patent duel in high-stakes RSV vaccine war
A patent battle is underway between GSK and Pfizer in the US, with the former calling for a jury trial over their respective RSV vaccines …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
